[ad_1]
Shares of small-cap pharmaceutical company Aarti Drugs rose as much as 2.95 per cent to Rs 528.85 per share on the BSE. The share price jumped on Friday after the company announced on Thursday that it had received a certificate of GMP compliance from the UK Medicines and Healthcare products Regulatory Agency (UK MHRA).
The certificate was issued to a manufacturing plant of its subsidiary (Pinnacle Life Science Private Limited) located at Baddi, Himachal Pradesh.
Click here to join us on WhatsApp
Aarti Drugs Limited (ADL), established in September 1984, is a manufacturer of active pharmaceutical ingredients (APIs), pharmaceutical intermediates and specialty chemicals. As part of the Aarti Group, a $900 million conglomerate, ADL has built a strong reputation in the industry.
The company offers more than 50 compounds in various therapeutic segments, including antibiotics, antiprotozoals, anti-inflammatories, antidiabetics, antifungals and cardioprotectants, strengthening its position as a market leader in APIs. Additionally, ADL has a wholly owned subsidiary, Pinnacle Life Science Private Limited, which specializes in formulation manufacturing.
Stock price history
The Aarti Drugs share price has underperformed the market as it has gained only 6 percent since the start of the year, while it rose only 0.5 percent during the of the last year. In comparison, the BSE Sensex is up 14.6 per cent year-to-date and 27 per cent year-on-year.
The company has a total market capitalization of Rs 4,790.76 crore. Its shares are trading at a price-to-earnings price of 36.54 times, while having an earnings per share of Rs 14.09.
At 11:38 am, the company’s share price rose 2.19 per cent to Rs 524.90 a piece on the BSE. In comparison, the BSE Sensex rose 0.39 per cent to the level of 82,815.73.
Q1FY25 Financial Expo
In Q1FY25, Aarti Drugs reported a 15.91 percent year-on-year decline in revenue, totaling Rs 556.45 crore, and a quarter-on-quarter decline of 10.4 percent over the last three months. The company’s net profit also fell 30.53 percent over the same period last year, reaching Rs 33.24 crore, with a quarterly decline of 29.83 percent in the last three months. .
First publication: October 4, 2024 | 11:43 a.m. STI